{"id":5290,"date":"2022-09-29T16:20:23","date_gmt":"2022-09-29T19:20:23","guid":{"rendered":"https:\/\/artica.capital\/clairfield-pilulas\/ma-no-setor-de-farmacos\/"},"modified":"2026-09-29T12:08:57","modified_gmt":"2026-09-29T15:08:57","slug":"ma-no-setor-de-farmacos","status":"publish","type":"pilulas","link":"https:\/\/artica.capital\/en\/clairfield-pilulas\/ma-no-setor-de-farmacos\/","title":{"rendered":"M&amp;A in the pharmaceutical sector"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">A produ\u00e7\u00e3o de f\u00e1rmacos \u00e9 marcada pela necessidade de investimentos massivos em inova\u00e7\u00e3o e fabrica\u00e7\u00e3o de novos produtos, al\u00e9m de incertezas associadas \u00e0 efetividade dos medicamentos em desenvolvimento.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Buscando superar as dificuldades inerentes do setor, movimenta\u00e7\u00f5es importantes aconteceram no Brasil nos \u00faltimos anos, seguindo uma tend\u00eancia de consolida\u00e7\u00e3o das grandes empresas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A p\u00edlula de hoje destaca quais as principais motiva\u00e7\u00f5es estrat\u00e9gicas para realiza\u00e7\u00e3o de M&amp;As no setor de f\u00e1rmacos, trazendo exemplos de transa\u00e7\u00f5es envolvendo companhias brasileiras.<\/p>\n\n\n\n<!-- pilula-html v1 -->\n<style>\n.pil{--navy:#2d3a51;--blue:#4f6388;--light:#8599b9;--pale:#e8ebf1;--card:#d3d9e3;--red:#c0272d;--txt:#333;font-family:\"Merriweather Sans\",sans-serif;color:var(--txt);margin-top:40px}\n.pil *{box-sizing:border-box}\n.pil img{max-width:100%;height:auto;display:block}\n.pil-sec{margin:0 0 56px}\n.pil-sec h2{background:var(--navy);color:#fff;font-size:19px;line-height:1.35;font-weight:700;padding:16px 20px;border-radius:0 0 28px 0;margin:0 0 20px;text-wrap:balance}\n.pil-sub{font-size:14px;font-weight:700;color:var(--navy);border-bottom:2px solid var(--navy);padding-bottom:6px;margin:0 0 16px;display:flex;justify-content:space-between;gap:12px;align-items:flex-end}\n.pil-tag{color:var(--red);border-top:2px solid var(--red);border-bottom:2px solid var(--red);font-size:12px;padding:2px 8px;white-space:nowrap}\n.pil-unit{font-size:12px;font-style:italic;color:#999;font-weight:700}\n.pil-src{font-size:11px;color:#777;margin-top:14px;line-height:1.5}\n.pil-p{font-size:14px;line-height:1.6;margin:0 0 12px}\n.pil-note{display:flex;gap:12px;align-items:center;background:var(--pale);border:1.5px dashed var(--navy);border-radius:10px;padding:12px 16px;font-size:14px;line-height:1.55;margin-top:18px}\n.pil-note::before{content:\"\";flex:none;width:26px;height:26px;border-radius:50%;background:var(--navy) url(\"data:image\/svg+xml,%3Csvg xmlns='http:\/\/www.w3.org\/2000\/svg' viewBox='0 0 24 24' fill='none' stroke='white' stroke-width='1.8' stroke-linecap='round'%3E%3Cpath d='M9 18h6M10 21h4M12 3a6 6 0 0 0-3.5 10.9c.6.5 1 1.2 1 2.1h5c0-.9.4-1.6 1-2.1A6 6 0 0 0 12 3z'\/%3E%3C\/svg%3E\") center\/16px no-repeat}\n.pil-note.solid{border-style:solid;background:#fff;box-shadow:0 2px 6px rgba(0,0,0,.12)}\n.pil-note.solid::before{display:none}\n.pil-grid2{display:grid;grid-template-columns:1fr 1fr;gap:24px}\n.pil-grid2.wide-left{grid-template-columns:1.75fr 1fr}\n.pil-grid2.wide-right{grid-template-columns:1fr 1.75fr}\n.pil-grid3{display:grid;grid-template-columns:repeat(3,1fr);gap:20px}\n.pil-grid4{display:grid;grid-template-columns:repeat(4,1fr);gap:16px}\n.pil-grid5{display:grid;grid-template-columns:repeat(5,1fr);gap:12px}\n.pil-grid2>*,.pil-grid3>*,.pil-grid4>*,.pil-grid5>*{min-width:0}\n.pil-legend{font-size:12px;display:flex;gap:14px;justify-content:flex-end;flex-wrap:wrap;margin-bottom:6px}\n.pil-legend span{display:inline-flex;align-items:center;gap:6px}\n.pil-legend i{width:14px;height:10px;display:inline-block}\n\/* grafico de colunas: .pil-bars > div[style=height:%] > span (valor); .pil-years > span *\/\n.pil-bars{display:flex;align-items:flex-end;gap:2.2%;height:240px;border-bottom:1.5px solid #333;padding:22px 1% 0}\n.pil-bars>div{flex:1;background:var(--light);position:relative;min-height:1px}\n.pil-bars>div.e{background:var(--blue)}\n.pil-bars>div.cur{background:var(--navy)}\n.pil-bars>div>span{position:absolute;top:-19px;left:50%;transform:translateX(-50%);font-size:12px;white-space:nowrap}\n.pil-years{display:flex;gap:2.2%;padding:4px 1% 0;font-size:11px;text-align:center}\n.pil-years span{flex:1}\n.pil-cagr{text-align:center;font-size:12px;font-weight:700}\n.pil-cagr span{display:inline-block;border:1.5px solid #222;border-radius:50%;padding:2px 8px;margin-top:4px}\n\/* barras horizontais: .pil-hbars > .r > (b nome) (.bar > i[style=width:%]) (em valor) *\/\n.pil-hbars{display:grid;gap:8px;font-size:13px}\n.pil-hbars .r{display:grid;grid-template-columns:minmax(90px,30%) 1fr auto;gap:10px;align-items:center}\n.pil-hbars .bar{background:var(--pale);height:18px}\n.pil-hbars .bar i{display:block;height:100%;background:var(--blue)}\n.pil-hbars em{font-style:normal;font-weight:700;color:var(--navy);min-width:48px;text-align:right}\n\/* cartoes de numeros *\/\n.pil-box{border:2px solid var(--navy);border-radius:0 0 10px 10px;background:#fff}\n.pil-box>h3{margin:0;background:var(--navy);color:#fff;font-size:14px;text-align:center;padding:8px}\n.pil-stat{text-align:center;padding:16px 14px;font-size:13px;line-height:1.45}\n.pil-stat strong{display:block;font-size:40px;color:var(--blue);font-weight:800;line-height:1.1}\n.pil-stat strong small{font-size:22px}\n.pil-stat em{font-style:normal;color:var(--blue);font-weight:700}\n.pil-card{background:#fff;border-radius:12px;box-shadow:0 1px 5px rgba(0,0,0,.14);padding:14px 16px;font-size:13px;line-height:1.5}\n.pil-card h3{font-size:15px;color:var(--navy);margin:0 0 8px}\n.pil-card.tint{background:var(--card);box-shadow:none}\n\/* listas e fatos *\/\n.pil-list{margin:0;padding-left:18px;font-size:14px;line-height:1.6}\n.pil-list li{margin-bottom:6px}\n.pil-fact{font-size:14px;line-height:1.5;padding-left:14px;border-left:3px solid var(--light)}\n.pil-fact.dark{border-color:var(--navy)}\n.pil-fact b{color:var(--navy)}\n.pil-fact big{font-size:20px;font-weight:800;color:var(--navy)}\n.pil-hl{color:var(--blue);font-weight:700}\n\/* tabela *\/\n.pil-tw{overflow-x:auto}\n.pil-table{width:100%;border-collapse:collapse;font-size:13px}\n.pil-table th{background:var(--navy);color:#fff;text-align:left;padding:8px 10px;font-weight:700}\n.pil-table td{padding:7px 10px;border-bottom:1px solid #d8dce4;vertical-align:top}\n.pil-table tr:nth-child(even) td{background:#f5f6f9}\n.pil-table .n{text-align:right;font-variant-numeric:tabular-nums;white-space:nowrap}\n\/* linha do tempo *\/\n.pil-time{display:grid;gap:14px;border-left:2px dashed var(--light);padding-left:18px;margin-left:6px}\n.pil-time>div{position:relative;font-size:14px;line-height:1.5}\n.pil-time>div::before{content:\"\";position:absolute;left:-25px;top:5px;width:12px;height:12px;border-radius:50%;background:var(--navy)}\n.pil-time b.y{display:block;color:var(--light);font-size:16px;font-weight:800}\n\/* figuras (recortes do slide) *\/\n.pil-fig{margin:0}\n.pil-fig figcaption{text-align:center;font-weight:800;color:var(--light);font-size:16px;margin-top:4px}\n.pil-brand{background:var(--card);border-radius:14px;overflow:hidden}\n.pil-brand p{margin:0;text-align:center;font-size:20px;font-weight:800;font-style:italic;color:var(--navy);padding:10px 0 12px}\n@media (max-width:700px){\n  .pil-grid2,.pil-grid2.wide-left,.pil-grid2.wide-right{grid-template-columns:1fr}\n  .pil-grid3,.pil-grid4,.pil-grid5{grid-template-columns:1fr 1fr}\n  .pil-sec h2{font-size:17px}\n  .pil-bars{height:180px}\n  .pil-bars>div>span{font-size:10px}\n  .pil-years{font-size:9px}\n}\n@media (max-width:480px){\n  .pil-bars{gap:1.2%}\n  .pil-years{gap:1.2%;font-size:8px}\n  .pil-bars>div>span{font-size:8px;letter-spacing:-.3px}\n  .pil-bars:has(>div:nth-child(13))>div>span{writing-mode:vertical-rl;transform:translateX(-50%) rotate(180deg);top:auto;bottom:100%;padding-bottom:2px}\n  .pil-years:has(>span:nth-child(13)) span{writing-mode:vertical-rl;transform:rotate(180deg);margin:0 auto}\n}\n<\/style>\n<div class=\"pil\">\n\n<section class=\"pil-sec\">\n  <h2>M&amp;As s\u00e3o alavancas-chave para o setor de desenvolvimento de f\u00e1rmacos, com 3 principais motiva\u00e7\u00f5es em destaque:<\/h2>\n  <div class=\"pil-sub\">Alavanca Estrat\u00e9gica<\/div>\n  <div class=\"pil-grid3\">\n    <div class=\"pil-card\" style=\"text-align:center\"><h3>Inova\u00e7\u00e3o<\/h3>A grande quantidade de etapas envolvida no desenvolvimento de um f\u00e1rmaco motiva a <span class=\"pil-hl\">aquisi\u00e7\u00e3o de empresas menores e com mais <i>expertise<\/i> em processos espec\u00edficos.<\/span><\/div>\n    <div class=\"pil-card\" style=\"text-align:center\"><h3>Economias de Escala<\/h3>Da pesquisa \u00e0 comercializa\u00e7\u00e3o do f\u00e1rmaco, existem grandes oportunidades de <span class=\"pil-hl\">parcerias estrat\u00e9gicas para reduzir custos e aumentar efici\u00eancia operacional.<\/span><\/div>\n    <div class=\"pil-card\" style=\"text-align:center\"><h3>Realinhamento de Portf\u00f3lio<\/h3>O longo processo de desenvolvimento de um f\u00e1rmaco exige um <span class=\"pil-hl\">portf\u00f3lio bem estruturado, com gera\u00e7\u00e3o de caixa suficiente at\u00e9 que novas patentes sejam obtidas.<\/span><\/div>\n  <\/div>\n  <div class=\"pil-sub\" style=\"margin-top:28px\">Opera\u00e7\u00e3o<\/div>\n  <div class=\"pil-grid3\">\n    <div class=\"pil-card\" style=\"text-align:center;background:#f2f2f2\"><img decoding=\"async\" src=\"https:\/\/artica.capital\/wp-content\/uploads\/2026\/09\/5290-ache.png\" alt=\"Logos da Ach\u00e9 e do Laborat\u00f3rio Tiaraju\" loading=\"lazy\" style=\"margin:0 auto 8px\">Ach\u00e9 adquirindo laborat\u00f3rio ga\u00facho Tiaraju, experiente no segmento de nutri cosm\u00e9ticos.<\/div>\n    <div class=\"pil-card\" style=\"text-align:center;background:#f2f2f2\"><img decoding=\"async\" src=\"https:\/\/artica.capital\/wp-content\/uploads\/2026\/09\/5290-hypera.png\" alt=\"Logos da Hypera Pharma e da Sanofi\" loading=\"lazy\" style=\"margin:0 auto 8px\">Hypera adquirindo ativos da Sanofi para integrar a produ\u00e7\u00e3o de medicamentos e diluir despesas.<\/div>\n    <div class=\"pil-card\" style=\"text-align:center;background:#f2f2f2\"><img decoding=\"async\" src=\"https:\/\/artica.capital\/wp-content\/uploads\/2026\/09\/5290-eurofarma.png\" alt=\"Logos da Eurofarma e da Takeda\" loading=\"lazy\" style=\"margin:0 auto 8px\">Eurofarma adquirindo ativos da Takeda em pa\u00edses da Am\u00e9rica Latina, expandindo sua opera\u00e7\u00e3o internacionalmente e ampliando o portf\u00f3lio protegido por patentes<\/div>\n  <\/div>\n  <div class=\"pil-src\">Fonte: McKinsey &#8211; A new prescription for M&amp;A in pharma; <i>Clippings;<\/i> An\u00e1lise \u00c1rtica<\/div>\n<\/section>\n\n<\/div>\n\n","protected":false},"excerpt":{"rendered":"<p>Pharmaceutical production is marked by the need for massive investments in innovation and the manufacture of new products, in addition to uncertainties associated with the effectiveness of drugs under development.<\/p>","protected":false},"author":1,"featured_media":5288,"template":"","meta":[],"class_list":["post-5290","pilulas","type-pilulas","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/artica.capital\/en\/wp-json\/wp\/v2\/pilulas\/5290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/artica.capital\/en\/wp-json\/wp\/v2\/pilulas"}],"about":[{"href":"https:\/\/artica.capital\/en\/wp-json\/wp\/v2\/types\/pilulas"}],"author":[{"embeddable":true,"href":"https:\/\/artica.capital\/en\/wp-json\/wp\/v2\/users\/1"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/artica.capital\/en\/wp-json\/wp\/v2\/media\/5288"}],"wp:attachment":[{"href":"https:\/\/artica.capital\/en\/wp-json\/wp\/v2\/media?parent=5290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}